tiprankstipranks
Trending News
More News >
Glenmark Life Sciences Limited (IN:GLS)
:GLS
India Market

Glenmark Life Sciences Limited (GLS) Price & Analysis

Compare
2 Followers

GLS Stock Chart & Stats


Financials

GLS FAQ

What was Glenmark Life Sciences Limited’s price range in the past 12 months?
Glenmark Life Sciences Limited lowest stock price was ₹821.00 and its highest was ₹1335.00 in the past 12 months.
    What is Glenmark Life Sciences Limited’s market cap?
    Glenmark Life Sciences Limited’s market cap is ₹124.09B.
      When is Glenmark Life Sciences Limited’s upcoming earnings report date?
      Glenmark Life Sciences Limited’s upcoming earnings report date is Aug 08, 2025 which is in 28 days.
        How were Glenmark Life Sciences Limited’s earnings last quarter?
        Glenmark Life Sciences Limited released its earnings results on May 15, 2025. The company reported ₹11.35 earnings per share for the quarter, beating the consensus estimate of ₹10.2 by ₹1.15.
          Is Glenmark Life Sciences Limited overvalued?
          According to Wall Street analysts Glenmark Life Sciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Glenmark Life Sciences Limited pay dividends?
            Glenmark Life Sciences Limited pays a Semiannually dividend of ₹22.5 which represents an annual dividend yield of 3.96%. See more information on Glenmark Life Sciences Limited dividends here
              What is Glenmark Life Sciences Limited’s EPS estimate?
              Glenmark Life Sciences Limited’s EPS estimate is 10.8.
                How many shares outstanding does Glenmark Life Sciences Limited have?
                Glenmark Life Sciences Limited has 122,629,150 shares outstanding.
                  What happened to Glenmark Life Sciences Limited’s price movement after its last earnings report?
                  Glenmark Life Sciences Limited reported an EPS of ₹11.35 in its last earnings report, beating expectations of ₹10.2. Following the earnings report the stock price went up 2.168%.
                    Which hedge fund is a major shareholder of Glenmark Life Sciences Limited?
                    Currently, no hedge funds are holding shares in IN:GLS

                    Company Description

                    Glenmark Life Sciences Limited

                    Glenmark Life Sciences Limited develops, manufactures, and supplies non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers Olmesartan, Amiodarone, Telmisartan, Perindopril, Rosuvastatin, and Cilostazol for cardiovascular diseases; Oxcarbazepine, Zonisamide, Topiramate, Bupropion, Ropinirole, Riluzole, and Lacosamide for central nervous system diseases; Glimepiride, Teneligliptin, Vildagliptin, and Linagliptin for diabetes; and Etoricoxib and Lornoxicam for pain management. It also provides Atovaquone, Voriconazole, Mirabegron, Desloratadine, Esomeprazole Magnesium, Adapalene, and Fluconazole gastro-intestinal disorders, anti-infective, respiratory, anti-emetic, and other therapeutic areas. In addition, the company offers contract development and manufacturing services to a range of multinational pharmaceutical and specialty pharmaceutical companies. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was incorporated in 2011 and is based in Mumbai, India. Glenmark Life Sciences Limited is a subsidiary of Glenmark Pharmaceuticals Limited.
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Caplin Point Laboratories Limited
                    Granules India Limited
                    Marksans Pharma Limited
                    Sanofi India Limited
                    Shilpa Medicare Limited
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis